[Cardiovascular risk associated with obesity and metabolic syndrome: the European point of view].
作者信息
Tounian P
机构信息
Gastroentérologie et Nutrition Pédiatriques, Hôpital Armand-Trousseau, 75571 Paris cedex 12, France.
出版信息
Arch Pediatr. 2009 Jun;16(6):687-8. doi: 10.1016/S0929-693X(09)74112-0.
Abstract
摘要
相似文献
1
[Cardiovascular risk associated with obesity and metabolic syndrome: the European point of view].
Arch Pediatr. 2009 Jun;16(6):687-8. doi: 10.1016/S0929-693X(09)74112-0.
2
Cardiovascular outcomes for obesity and metabolic syndrome.
Obes Res. 2002 Nov;10 Suppl 1:27S-32S. doi: 10.1038/oby.2002.186.
3
[Obesity and the metabolic syndrome--more questions than answers?].
Vnitr Lek. 2007 Apr;53(4):441-3.
4
Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
Nat Clin Pract Cardiovasc Med. 2008 Jul;5 Suppl 1:S10-4. doi: 10.1038/ncpcardio1271.
5
Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
J Cardiometab Syndr. 2008 Summer;3(3):147-8. doi: 10.1111/j.1559-4572.2008.00007.x.
6
[Obesity, the metabolic syndrome and cardiovascular disease].
Ugeskr Laeger. 2004 Apr 19;166(17):1561-4.
7
[Cardiovascular risk and metabolic syndrome in youth: Canadian perspectives].
Arch Pediatr. 2009 Jun;16(6):689-91. doi: 10.1016/S0929-693X(09)74113-2.
8
Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Am J Cardiol. 2008 Dec 22;102(12A):1L-3L. doi: 10.1016/j.amjcard.2008.09.066.
9
Metabolic syndrome and cardiovascular disease.
Acta Med Indones. 2006 Oct-Dec;38(4):177-8.
10
Metabolic syndrome and cardiovascular risk factors in the menopausal transition.
Gynecol Endocrinol. 2010 Jan;26(1):1-3. doi: 10.3109/09513590903080969.
Zotero 插件